The end-to-end platform for CNS clinical trials
As a leader in cognitive assessment technology for drug development, we have over 30 years’ experience enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval. Our platform supports sponsors to improve recruitment, develop safe and effective treatments, and enhance R&D efficiency.
We work with you from the beginning to understand your study objectives and to develop a study protocol that is optimised for success. Our team of experienced neuroscientists and project managers support you through the lifecycle of your study from data collection to analysis to maximise the validity of outcomes.
Dedicated support team to guide sponsors and sites throughout your clinical study
Quality management system that meets the needs of regulatory submissions
Recognised operational excellence, with 100% customers recommending us
Supporting your clinical study from inception to completion
Study success & support
Data management reporting
Designed to improve measurement accuracy, reduce patient and site burden, our suite of technologies facilitates in-clinic, at-home and decentralised clinical trials.
Electronic questionnaires & scales
High frequency testing
Decentralised clinical trials
Since CANTAB® was first developed, our digital cognitive assessments have been validated in over 3,000 publications in more than 250 indications. Take a closer look at some of the therapeutic areas that have benefitted from our expertise.
Trusted by the world’s top organisations
Our clients include the world’s top 20 pharmaceutical and biotechnology companies, specialist contract research organisations, leading academic research institutions and international healthcare providers.
100+ countries where our technologies have been remotely deployed
patients assessed on our digital health tools
95% engagement from patients using our technology in trials